BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11350903)

  • 1. Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
    Kawamoto T; Shoda J; Irimura T; Miyahara N; Furukawa M; Ueda T; Asano T; Kano M; Koike N; Fukao K; Tanaka N; Todoroki T
    Clin Cancer Res; 2001 May; 7(5):1333-42. PubMed ID: 11350903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular localization of MUC1 recognized by a monoclonal antibody MY.1E12 correlates with postsurgical prognosis in differentiated-type gastric carcinomas of stage II and III.
    Shinozaki E; Adachi S; Shoda J; Kawamoto T; Suzuki H; Irimura T; Ohkohchi N
    Int J Oncol; 2004 Nov; 25(5):1257-65. PubMed ID: 15492813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MUC1 recognized by a monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of carcinoma of the gallbladder.
    Kawamoto T; Shoda J; Miyahara N; Suzuki H; Furukawa M; Todoroki T; Tanaka N; Irimura T
    Clin Exp Metastasis; 2004; 21(4):353-62. PubMed ID: 15554392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
    Kawamoto T; Shoda J; Asano T; Ueda T; Furukawa M; Koike N; Tanaka N; Todoroki T; Miwa M
    Int J Cancer; 2002 Mar; 98(3):427-34. PubMed ID: 11920595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
    Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
    Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients.
    Fujita K; Denda K; Yamamoto M; Matsumoto T; Fujime M; Irimura T
    Br J Cancer; 1999 Apr; 80(1-2):301-8. PubMed ID: 10390012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma.
    Suzuki H; Shoda J; Kawamoto T; Shinozaki E; Miyahara N; Hotta S; Iizuka Y; Nakahara A; Tanaka N; Yanaka A; Irimura T
    Clin Exp Metastasis; 2004; 21(4):321-9. PubMed ID: 15554388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study.
    Yamato T; Sasaki M; Watanabe Y; Nakanuma Y
    J Pathol; 1999 May; 188(1):30-7. PubMed ID: 10398137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.
    Miyahara N; Shoda J; Kawamoto T; Furukawa M; Ueda T; Todoroki T; Tanaka N; Matsuo K; Yamada Y; Kohno K; Irimura T
    Clin Cancer Res; 2004 Mar; 10(6):2090-9. PubMed ID: 15041730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
    Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
    Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of sialylated MUC1 in prostate cancer: relationship to clinical stage and prognosis.
    Arai T; Fujita K; Fujime M; Irimura T
    Int J Urol; 2005 Jul; 12(7):654-61. PubMed ID: 16045558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.
    Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T
    Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
    Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
    Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
    Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy.
    Tanaka M; Kitajima Y; Sato S; Miyazaki K
    Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas.
    Wang JY; Chang CT; Hsieh JS; Lee LW; Huang TJ; Chai CY; Lin SR
    J Surg Oncol; 2003 Aug; 83(4):253-60. PubMed ID: 12884239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of morphologic subdivision of papillary renal cell carcinoma and MUC1 expression].
    Blel A; Kourda N; Baltagi Ben Jilani S; Zermani R
    Prog Urol; 2008 Oct; 18(9):575-9. PubMed ID: 18986629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer.
    Ohno T; Aihara R; Kamiyama Y; Mochiki E; Asao T; Kuwano H
    Eur J Cancer; 2006 Jan; 42(2):256-63. PubMed ID: 16356709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic alterations of mucins and cytokeratins during gallbladder carcinogenesis.
    Chang HJ; Kim SW; Lee BL; Hong EK; Kim WH
    Pathol Int; 2004 Aug; 54(8):576-84. PubMed ID: 15260848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma.
    Ichikawa T; Yamamoto T; Uenishi T; Tanaka H; Takemura S; Ogawa M; Tanaka S; Suehiro S; Hirohashi K; Kubo S
    J Hepatobiliary Pancreat Surg; 2006; 13(3):245-51. PubMed ID: 16708303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.